344 related articles for article (PubMed ID: 28182820)
1. No Beneficial Effects of Resveratrol on the Metabolic Syndrome: A Randomized Placebo-Controlled Clinical Trial.
Kjær TN; Ornstrup MJ; Poulsen MM; Stødkilde-Jørgensen H; Jessen N; Jørgensen JOL; Richelsen B; Pedersen SB
J Clin Endocrinol Metab; 2017 May; 102(5):1642-1651. PubMed ID: 28182820
[TBL] [Abstract][Full Text] [Related]
2. Fenofibrate reduces systemic inflammation markers independent of its effects on lipid and glucose metabolism in patients with the metabolic syndrome.
Belfort R; Berria R; Cornell J; Cusi K
J Clin Endocrinol Metab; 2010 Feb; 95(2):829-36. PubMed ID: 20061429
[TBL] [Abstract][Full Text] [Related]
3. Resveratrol increases bone mineral density and bone alkaline phosphatase in obese men: a randomized placebo-controlled trial.
Ornstrup MJ; Harsløf T; Kjær TN; Langdahl BL; Pedersen SB
J Clin Endocrinol Metab; 2014 Dec; 99(12):4720-9. PubMed ID: 25322274
[TBL] [Abstract][Full Text] [Related]
4. Age, abdominal obesity, and baseline high-sensitivity C-reactive protein are associated with low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B responses to ezetimibe/simvastatin and atorvastatin in patients with metabolic syndrome.
Robinson JG; Ballantyne CM; Hsueh WA; Rosen JB; Lin J; Shah AK; Tomassini JE; Lowe RS; Tershakovec AM
J Clin Lipidol; 2013; 7(4):292-303. PubMed ID: 23890516
[TBL] [Abstract][Full Text] [Related]
5. The role of multicomponent therapy in the metabolic syndrome, inflammation and cardiovascular risk in obese adolescents.
Masquio DC; de Piano A; Campos RM; Sanches PL; Carnier J; Corgosinho FC; Netto BD; Carvalho-Ferreira JP; Oyama LM; Nascimento CM; de Mello MT; Tufik S; Dâmaso AR
Br J Nutr; 2015 Jun; 113(12):1920-30. PubMed ID: 25907896
[TBL] [Abstract][Full Text] [Related]
6. Testosterone therapy prevents gain in visceral adipose tissue and loss of skeletal muscle in nonobese aging men.
Allan CA; Strauss BJ; Burger HG; Forbes EA; McLachlan RI
J Clin Endocrinol Metab; 2008 Jan; 93(1):139-46. PubMed ID: 17940111
[TBL] [Abstract][Full Text] [Related]
7. Menopause Is a Determinant of Breast Aromatase Expression and Its Associations With BMI, Inflammation, and Systemic Markers.
Brown KA; Iyengar NM; Zhou XK; Gucalp A; Subbaramaiah K; Wang H; Giri DD; Morrow M; Falcone DJ; Wendel NK; Winston LA; Pollak M; Dierickx A; Hudis CA; Dannenberg AJ
J Clin Endocrinol Metab; 2017 May; 102(5):1692-1701. PubMed ID: 28323914
[TBL] [Abstract][Full Text] [Related]
8. Life-long endurance exercise in humans: circulating levels of inflammatory markers and leg muscle size.
Mikkelsen UR; Couppé C; Karlsen A; Grosset JF; Schjerling P; Mackey AL; Klausen HH; Magnusson SP; Kjær M
Mech Ageing Dev; 2013; 134(11-12):531-40. PubMed ID: 24287006
[TBL] [Abstract][Full Text] [Related]
9. Effect of rimonabant on the high-triglyceride/ low-HDL-cholesterol dyslipidemia, intraabdominal adiposity, and liver fat: the ADAGIO-Lipids trial.
Després JP; Ross R; Boka G; Alméras N; Lemieux I;
Arterioscler Thromb Vasc Biol; 2009 Mar; 29(3):416-23. PubMed ID: 19112166
[TBL] [Abstract][Full Text] [Related]
10. Potential Effects of Omega-3 Fatty Acids on Insulin Resistance and Lipid Profile in Maintenance Hemodialysis Patients: a Randomized Placebo-Controlled Trial.
Gharekhani A; Dashti-Khavidaki S; Lessan-Pezeshki M; Khatami MR
Iran J Kidney Dis; 2016 Sep; 10(5):310-318. PubMed ID: 27721230
[TBL] [Abstract][Full Text] [Related]
11. Gastric mucosal devitalization reduces adiposity and improves lipid and glucose metabolism in obese rats.
Oberbach A; Schlichting N; Heinrich M; Kullnick Y; Retschlag U; Lehmann S; Khashab MA; Kalloo AN; Kumbhari V
Gastrointest Endosc; 2018 Jan; 87(1):288-299.e6. PubMed ID: 28479494
[TBL] [Abstract][Full Text] [Related]
12. Combined epigallocatechin-3-gallate and resveratrol supplementation for 12 wk increases mitochondrial capacity and fat oxidation, but not insulin sensitivity, in obese humans: a randomized controlled trial.
Most J; Timmers S; Warnke I; Jocken JW; van Boekschoten M; de Groot P; Bendik I; Schrauwen P; Goossens GH; Blaak EE
Am J Clin Nutr; 2016 Jul; 104(1):215-27. PubMed ID: 27194304
[TBL] [Abstract][Full Text] [Related]
13. Long-term testosterone treatment in elderly men with hypogonadism and erectile dysfunction reduces obesity parameters and improves metabolic syndrome and health-related quality of life.
Yassin DJ; Doros G; Hammerer PG; Yassin AA
J Sex Med; 2014 Jun; 11(6):1567-76. PubMed ID: 24712761
[TBL] [Abstract][Full Text] [Related]
14. A Palaeolithic-type diet causes strong tissue-specific effects on ectopic fat deposition in obese postmenopausal women.
Ryberg M; Sandberg S; Mellberg C; Stegle O; Lindahl B; Larsson C; Hauksson J; Olsson T
J Intern Med; 2013 Jul; 274(1):67-76. PubMed ID: 23414424
[TBL] [Abstract][Full Text] [Related]
15. Effects of gemigliptin, a dipeptidyl peptidase-4 inhibitor, on lipid metabolism and endotoxemia after a high-fat meal in patients with type 2 diabetes.
Ahn CH; Kim EK; Min SH; Oh TJ; Cho YM
Diabetes Obes Metab; 2017 Mar; 19(3):457-462. PubMed ID: 27868366
[TBL] [Abstract][Full Text] [Related]
16. Relation of high-sensitivity C-reactive protein, interleukin-6, tumor necrosis factor-alpha, and fibrinogen to abdominal adipose tissue, blood pressure, and cholesterol and triglyceride levels in healthy postmenopausal women.
Piché ME; Lemieux S; Weisnagel SJ; Corneau L; Nadeau A; Bergeron J
Am J Cardiol; 2005 Jul; 96(1):92-7. PubMed ID: 15979442
[TBL] [Abstract][Full Text] [Related]
17. Cardiorespiratory Fitness and Adiposity as Determinants of Metabolic Health-Pooled Analysis of Two Twin Cohorts.
Jukarainen S; Holst R; Dalgård C; Piirilä P; Lundbom J; Hakkarainen A; Lundbom N; Rissanen A; Kaprio J; Kyvik KO; Sørensen TIA; Pietiläinen KH
J Clin Endocrinol Metab; 2017 May; 102(5):1520-1528. PubMed ID: 28324016
[TBL] [Abstract][Full Text] [Related]
18. The metabolic effects of preferential reduction of visceral adipose tissue in abdominally obese men.
Marks SJ; Chin S; Strauss BJ
Int J Obes Relat Metab Disord; 1998 Sep; 22(9):893-8. PubMed ID: 9756248
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of yellow pea fibre supplementation on weight loss and the gut microbiota: a randomized controlled trial.
Lambert JE; Parnell JA; Han J; Sturzenegger T; Paul HA; Vogel HJ; Reimer RA
BMC Gastroenterol; 2014 Apr; 14():69. PubMed ID: 24712378
[TBL] [Abstract][Full Text] [Related]
20. Impact of Hypocaloric Hyperproteic Diet on Gut Microbiota in Overweight or Obese Patients with Nonalcoholic Fatty Liver Disease: A Pilot Study.
Pataky Z; Genton L; Spahr L; Lazarevic V; Terraz S; Gaïa N; Rubbia-Brandt L; Golay A; Schrenzel J; Pichard C
Dig Dis Sci; 2016 Sep; 61(9):2721-31. PubMed ID: 27142672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
